Georgia Clinical Research   Report issue

For profit Phase 2
Founded: Atlanta GA United States (2004)
Status: No NME R&D (2004)

Organization Overview

First Clinical Trial
2007
NCT00419263
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2007

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 2 Trials (1)

peramivir (rapivab) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Influenza, Human (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 1
  • # of Trial APIs: 1